200 related articles for article (PubMed ID: 29081410)
1. Whole-exome sequencing to identify novel mutations of nevoid basal cell carcinoma syndrome in a Chinese population.
Lu N; Wang J; Zhu B; Zhang M; Qi F; Wang X; Gu J
Cancer Biomark; 2017 Dec; 21(1):161-168. PubMed ID: 29081410
[TBL] [Abstract][Full Text] [Related]
2. Targeted exome sequencing and chromosomal microarray for the molecular diagnosis of nevoid basal cell carcinoma syndrome.
Matsudate Y; Naruto T; Hayashi Y; Minami M; Tohyama M; Yokota K; Yamada D; Imoto I; Kubo Y
J Dermatol Sci; 2017 Jun; 86(3):206-211. PubMed ID: 28342698
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic profiling of nevoid basal cell carcinoma syndrome in Korean patients by whole-exome sequencing.
Kim B; Kim MJ; Hur K; Jo SJ; Ko JM; Park SS; Seong MW; Mun JH
Sci Rep; 2021 Jan; 11(1):1163. PubMed ID: 33441926
[TBL] [Abstract][Full Text] [Related]
4. Novel PTCH1 Mutation Causes Gorlin-Goltz Syndrome.
Yue HT; Cao HY; He M
Chin J Dent Res; 2024 Mar; 27(1):83-88. PubMed ID: 38546523
[TBL] [Abstract][Full Text] [Related]
5. A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family.
Fan Z; Li J; Du J; Zhang H; Shen Y; Wang CY; Wang S
J Med Genet; 2008 May; 45(5):303-8. PubMed ID: 18285427
[TBL] [Abstract][Full Text] [Related]
6. A novel splicing mutation of PTCH1 in a Chinese family with nevoid basal cell carcinoma syndrome.
Zhou J; Zhang G; Shi M; Liu Z; Xiao M; Fu S; Gong X; Shi X
Med Mol Morphol; 2019 Dec; 52(4):235-237. PubMed ID: 30997576
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation of the PTCH1 gene activates the Shh/Gli signaling pathway in a Chinese family with nevoid basal cell carcinoma syndrome.
Zhang T; Chen M; Lü Y; Xing Q; Chen W
Biochem Biophys Res Commun; 2011 Jun; 409(2):166-70. PubMed ID: 21514272
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.
Hasan Ali O; Yurchenko AA; Pavlova O; Sartori A; Bomze D; Higgins R; Ring SS; Hartmann F; Bühler D; Fritzsche FR; Jochum W; Navarini AA; Kim A; French LE; Dermitzakis E; Christiano AM; Hohl D; Bickers DR; Nikolaev SI; Flatz L
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):396-402. PubMed ID: 32564428
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing of nevoid basal cell carcinoma syndrome families and review of Human Gene Mutation Database PTCH1 mutation data.
Gianferante DM; Rotunno M; Dean M; Zhou W; Hicks BD; Wyatt K; Jones K; Wang M; Zhu B; Goldstein AM; Mirabello L
Mol Genet Genomic Med; 2018 Nov; 6(6):1168-1180. PubMed ID: 30411536
[TBL] [Abstract][Full Text] [Related]
10. Gorlin-like phenotype in a patient with a PTCH2 variant of uncertain significance.
Casano K; Meddaugh H; Zambrano RM; Marble M; Torres JI; Lacassie Y
Eur J Med Genet; 2020 Apr; 63(4):103842. PubMed ID: 31945512
[TBL] [Abstract][Full Text] [Related]
11. A Novel PTCH1 Frameshift Mutation Leading to Nevoid Basal Cell Carcinoma Syndrome.
Durmaz CD; Evans G; Smith MJ; Ertop P; Akay BN; Tuncalı T
Cytogenet Genome Res; 2018; 154(2):57-61. PubMed ID: 29544218
[TBL] [Abstract][Full Text] [Related]
12. PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review.
Guo YY; Zhang JY; Li XF; Luo HY; Chen F; Li TJ
PLoS One; 2013; 8(10):e77305. PubMed ID: 24204797
[TBL] [Abstract][Full Text] [Related]
13. Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome.
Fujii K; Ohashi H; Suzuki M; Hatsuse H; Shiohama T; Uchikawa H; Miyashita T
Fam Cancer; 2013 Dec; 12(4):611-4. PubMed ID: 23479190
[TBL] [Abstract][Full Text] [Related]
14. Nevoid Basal Cell Carcinoma Syndrome:
Martinez MF; Romano MV; Martinez AP; González A; Muchnik C; Stengel FM; Mazzuoccolo LD; Azurmendi PJ
Cells; 2019 Feb; 8(2):. PubMed ID: 30754660
[TBL] [Abstract][Full Text] [Related]
15. PTCH2 is not a strong candidate gene for gorlin syndrome predisposition.
Smith MJ; Evans DG
Fam Cancer; 2022 Jul; 21(3):343-346. PubMed ID: 34170463
[TBL] [Abstract][Full Text] [Related]
16. [Nevoid basal cell carcinoma syndrome with corpus callosum agenesis, PTCH1 mutation and absence of basal cell carcinoma].
Mazzuoccolo LD; Martínez MF; Muchnik C; Azurmendi PJ; Stengel F
Medicina (B Aires); 2014; 74(4):307-10. PubMed ID: 25188659
[TBL] [Abstract][Full Text] [Related]
17. Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype.
Onodera S; Saito A; Hasegawa D; Morita N; Watanabe K; Nomura T; Shibahara T; Ohba S; Yamaguchi A; Azuma T
PLoS One; 2017; 12(9):e0184702. PubMed ID: 28915250
[TBL] [Abstract][Full Text] [Related]
18. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.
Barraud S; Delemer B; Poirsier-Violle C; Bouligand J; Mérol JC; Grange F; Higel-Chaufour B; Decoudier B; Zalzali M; Dwyer AA; Acierno JS; Pitteloud N; Millar RP; Young J
Neuroendocrinology; 2021; 111(1-2):99-114. PubMed ID: 32074614
[TBL] [Abstract][Full Text] [Related]
19. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.
Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K
Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011
[TBL] [Abstract][Full Text] [Related]
20.
Ponti G; Manfredini M; Pastorino L; Maccaferri M; Tomasi A; Pellacani G
Anticancer Res; 2018 Jan; 38(1):471-476. PubMed ID: 29277811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
